Back to
VIKING GLOBAL INVESTORS LP
BBIO29 quarters
Position history for
VIKING GLOBAL INVESTORS LP's holdings in BRIDGEBIO PHARMA INC
VIKING GLOBAL INVESTORS LP holds 9.9M shares of BBIO (BRIDGEBIO PHARMA INC), worth $741M as of 2026-Q2. The position was decreased (-16.0% shares). BBIO represents 2.1% of VIKING GLOBAL INVESTORS LP's portfolio.
Current Value
$741M
Current Shares
9.9M
Total Value Change
+$23M
Total Shares Change
-16.7M
Quarter-by-Quarter History
Other major holders of BBIO: VANGUARD GROUP INC, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, Janus Henderson Group Ltd.